» Articles » PMID: 3972418

Improved Identification of Heterozygotes for Homocystinuria Due to Cystathionine Synthase Deficiency by the Combination of Methionine Loading and Enzyme Determination in Cultured Fibroblasts

Overview
Journal Hum Genet
Specialty Genetics
Date 1985 Jan 1
PMID 3972418
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Previous data on tentative identification of the carrier state for homocystinuria due to cystathionine synthase deficiency using methionine loading or measurement of cystathionine synthase activity in tissue extracts are conflicting. We studied the results of standardized oral methionine loading in 20 obligate heterozygotes and compared them with those of determination of cystathionine synthase activity in cultured fibroblasts. Special attention was devoted to our recently reported observation on the small but striking differences in methionine metabolism between healthy pre- and postmenopausal women and men. Fasting and after load peak levels of methionine in serum did not discriminate the carriers from the control subjects. The mean fasting level of total homocysteine was only significantly higher in the group of premenopausal heterozygotes than in the corresponding control group. Nevertheless, the individual values overlapped with the normal range in 4 of 12 premenopausal heterozygotes. After loading peak levels of total homocysteine in 18 out of the 20 obligate heterozygotes exceeded the upper limit of the ranges in the three control groups. Thus, this parameter discriminated 90% of the obligate carriers. Measurement of cystathionine synthase activity in cultured fibroblasts from a skin biopsy identified the obligate heterozygotes to a similar degree (85%). No significant correlation between the measurements of cystathionine synthase activity and the after load peak levels of total homocysteine in the individual heterozygotes was established. Combination of both methionine loading and determination of cystathionine synthase activity in cultured fibroblasts identified all of these carriers.

Citing Articles

Influence of genetic and environmental factors in peripheral arterial disease natural history: Analysis from six years follow up.

Archetti S, Martini M, Botteri E, Di Lorenzo D, Cervi E, Bonardelli S Int J Appl Basic Med Res. 2013; 2(2):117-22.

PMID: 23776824 PMC: 3678691. DOI: 10.4103/2229-516X.106354.


Hyperhomocysteinemia and thrombosis.

Cattaneo M Lipids. 2002; 36 Suppl:S13-26.

PMID: 11837987 DOI: 10.1007/s11745-001-0677-9.


The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.

Kluijtmans L, Boers G, Kraus J, van den Heuvel L, Cruysberg J, Trijbels F Am J Hum Genet. 1999; 65(1):59-67.

PMID: 10364517 PMC: 1378075. DOI: 10.1086/302439.


Disorders of homocysteine metabolism.

Fowler B J Inherit Metab Dis. 1997; 20(2):270-85.

PMID: 9211199 DOI: 10.1023/a:1005369109055.


Homocystinuria: what about mild hyperhomocysteinaemia?.

van den Berg M, Boers G Postgrad Med J. 1996; 72(851):513-8.

PMID: 8949585 PMC: 2398569. DOI: 10.1136/pgmj.72.851.513.


References
1.
Dunn H, Perry T, DOLMAN C . Homocystinuria. A recently discovered cause of mental defect and cerebrovascular thrombosis. Neurology. 1966; 16(4):407-20. DOI: 10.1212/wnl.16.4.407. View

2.
UHLENDORF B, Conerly E, Mudd S . Homocystinuria: studies in tissue culture. Pediatr Res. 1973; 7(7):645-58. DOI: 10.1203/00006450-197307000-00008. View

3.
Kennedy C, Shih V, Rowland L . Homocystinuria: a report in two siblings. Pediatrics. 1965; 36(5):736-41. View

4.
Bittles A, CARSON N . Homocystinuria: the effect of pyridoxine supplementation on cultured skin fibroblasts. J Inherit Metab Dis. 1981; 4(1):7-9. DOI: 10.1007/BF02263574. View

5.
Boers G, Polder T, Cruysberg J, Schoonderwaldt H, Peetoom J, Van Ruyven T . Homocystinuria versus Marfan's syndrome: the therapeutic relevance of the differential diagnosis. Neth J Med. 1984; 27(6):206-12. View